Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VAISHALI PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 VAISHALI PHARMA    TEVA PHARMA
EQUITY SHARE DATA
    VAISHALI PHARMA
Mar-23
TEVA PHARMA
Dec-13
VAISHALI PHARMA /
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1943,479-   
Low Rs643,022-   
Sales per share (Unadj.) Rs66.01,996.4-  
Earnings per share (Unadj.) Rs6.3124.7-  
Cash flow per share (Unadj.) Rs6.7286.1-  
Dividends per share (Unadj.) Rs0109.18-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs31.32,217.6-  
Shares outstanding (eoy) m10.55848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.01.6 120.0%   
Avg P/E ratio x20.626.1 79.1%  
P/CF ratio (eoy) x19.111.4 168.5%  
Price / Book Value ratio x4.11.5 281.6%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m1,3612,756,220 0.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m130-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m6971,692,969 0.0%  
Other income Rs m220-   
Total revenues Rs m7191,692,969 0.0%   
Gross profit Rs m94463,620 0.0%  
Depreciation Rs m5136,844 0.0%   
Interest Rs m2333,253 0.1%   
Profit before tax Rs m88293,523 0.0%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m22-3,584 -0.6%   
Profit after tax Rs m66105,758 0.1%  
Gross profit margin %13.527.4 49.2%  
Effective tax rate %25.4-1.2 -2,076.6%   
Net profit margin %9.56.2 151.7%  
BALANCE SHEET DATA
Current assets Rs m7271,143,425 0.1%   
Current liabilities Rs m321997,163 0.0%   
Net working cap to sales %58.38.6 674.7%  
Current ratio x2.31.1 197.6%  
Inventory Days Days1891 19.8%  
Debtors Days Days2,80996 2,928.6%  
Net fixed assets Rs m61552,961 0.0%   
Share capital Rs m1054,167 2.5%   
"Free" reserves Rs m2240-   
Net worth Rs m3301,880,567 0.0%   
Long term debt Rs m52865,653 0.0%   
Total assets Rs m7883,868,976 0.0%  
Interest coverage x4.99.8 50.1%   
Debt to equity ratio x0.20.5 34.4%  
Sales to assets ratio x0.90.4 202.1%   
Return on assets %11.23.6 313.1%  
Return on equity %20.05.6 356.1%  
Return on capital %29.14.9 589.4%  
Exports to sales %25.20-   
Imports to sales %7.80-   
Net fx Rs m1210-   
CASH FLOW
From Operations Rs m11269,772 0.0%  
From Investments Rs m3-95,591 -0.0%  
From Financial Activity Rs m-17-323,609 0.0%  
Net Cashflow Rs m-4-149,429 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare VAISHALI PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare VAISHALI PHARMA With: SEQUENT SCIENTIFIC  SHREE GANESH REMEDIES   MAKERS LAB.  SUN PHARMA  ALKEM LABORATORIES  



Today's Market

Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5% Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5%(Closing)

After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.